Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Closes Tacere Acquisition

Premium

Benitec Biopharma last week said that it has completed its acquisition of Tacere Therapeutics, which was first announced last month.

As reported by Gene Silencing News, Benitec acquired Tacere and its preclinical hepatitis C program for just under $1.5 million in stock (GSN 10/11/2012).

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.